These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 7123066)
41. Estimation of the time-dependent vaccine efficacy from a measles epidemic. Eichner M; Diebner HH; Schubert C; Kreth HW; Dietz K Stat Med; 2002 Aug; 21(16):2355-68. PubMed ID: 12210620 [TBL] [Abstract][Full Text] [Related]
42. Measles vaccine efficacy in India: a review. Singh J; Datta KK J Commun Dis; 1997 Mar; 29(1):47-56. PubMed ID: 9282529 [TBL] [Abstract][Full Text] [Related]
43. [Measles and rubella]. Takayama N Rinsho Byori; 2005 Sep; 53(9):845-52. PubMed ID: 16235838 [TBL] [Abstract][Full Text] [Related]
45. [Serological survey of measles in children from 5 to 15 months of age in Curitiba and São José dos Pinhais, State of Paraná, Brazil, 1983]. Rodriguez MA; Skraba I; Maluf EP; Nazareno ER; Cavalcanti AP; de Mattos NP; Cabrine O Rev Saude Publica; 1984 Dec; 18(6):421-8. PubMed ID: 6536112 [No Abstract] [Full Text] [Related]
46. Seroconversion after measles vaccination at nine and fifteen months of age. Işik N; Uzel N; Gökçay G; Kiliç A; Yilmaz G; Sadikoğlu B; Diri S Pediatr Infect Dis J; 2003 Aug; 22(8):691-5. PubMed ID: 12913768 [TBL] [Abstract][Full Text] [Related]
47. [Duration of the immunity of attenuated measles vaccine. IV. Result of a 9-year observation following primary inoculation]. Zhonghua Yi Xue Za Zhi; 1983 Jul; 63(7):423-5. PubMed ID: 6416645 [No Abstract] [Full Text] [Related]
48. [Vaccination against measles by live vaccines. 2 experiments in tropical Africa (Senegal)]. Rey M; Baylet R; Cantrelle P; Diop I; Dauchy S Presse Med (1893); 1965 Nov; 73(48):2729-34. PubMed ID: 5842109 [No Abstract] [Full Text] [Related]
49. Vaccination of college students with attenuated live measles vaccine. Mitus A N Engl J Med; 1985 May; 312(20):1326. PubMed ID: 3990732 [No Abstract] [Full Text] [Related]
50. Studies on the combined use of killed and live measles vaccines. IV. Fou years follow-up. Ueda S; Takahashi M; Hosai H; Yamanishi K; Okuno Y Biken J; 1969 Jun; 12(2):69-75. PubMed ID: 5346351 [No Abstract] [Full Text] [Related]
51. [Seroprevalence of measles antibodies in a pediatric population from Botucatu, São Paulo State, Brazil]. Godoy Id; Meira DA Rev Soc Bras Med Trop; 2000; 33(3):259-64. PubMed ID: 10967594 [TBL] [Abstract][Full Text] [Related]
52. [Vaccination against measles should be given higher priority]. Skinhøj P Ugeskr Laeger; 2013 Feb; 175(9):565. PubMed ID: 23608004 [No Abstract] [Full Text] [Related]
53. [Measles vaccination. Israeli studies with live attenuated measles virus vaccine and gamma globulin]. LEVIN S; MOSES S; SHIMANSKY L; KRUGMAN S Harefuah; 1962 Sep; 63():161-6. PubMed ID: 14464579 [No Abstract] [Full Text] [Related]
54. [IMMUNIZATION AGAINST MEASLES; ATTENUATED VIRUS VACCINES VERSUS INACTIVATED VIRUS VACCINES]. VERONESI R Pediatr Prat; 1964; 35():141-8. PubMed ID: 14239134 [No Abstract] [Full Text] [Related]
55. [Analysis and evaluation on quality of live attenuated measles vaccine from market surveillance sampling]. Fang HH; Wang XX; Yi M Zhongguo Yi Miao He Mian Yi; 2009 Dec; 15(6):511-5. PubMed ID: 20518326 [TBL] [Abstract][Full Text] [Related]